Literature DB >> 20544736

TRPM1: the endpoint of the mGluR6 signal transduction cascade in retinal ON-bipolar cells.

Catherine W Morgans1, Ronald Lane Brown, Robert M Duvoisin.   

Abstract

For almost 30 years the ion channel that initiates the ON visual pathway in vertebrate vision has remained elusive. Recent findings now indicate that the pathway, which begins with unbinding of glutamate from the metabotropic glutamate receptor 6 (mGluR6), ends with the opening of the transient receptor potential (TRP)M1 cation channel. As a component of the mGluR6 signal transduction pathway, mutations in TRPM1 would be expected to cause congenital stationary night blindness (CSNB), and several such mutations have already been identified in CSNB families. Furthermore, expression of TRPM1 in both the retina and skin raises the possibility that a genetic link exists between certain types of visual and skin disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544736      PMCID: PMC4238414          DOI: 10.1002/bies.200900198

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  43 in total

1.  OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity.

Authors:  R Strotmann; C Harteneck; K Nunnenmacher; G Schultz; T D Plant
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

2.  Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform.

Authors:  X Z Xu; F Moebius; D L Gill; C Montell
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

Review 3.  G proteins and phototransduction.

Authors:  Vadim Y Arshavsky; Trevor D Lamb; Edward N Pugh
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

4.  Origin of transient and sustained responses in ganglion cells of the retina.

Authors:  G B Awatramani; M M Slaughter
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

5.  Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia.

Authors:  Roxanne Y Walder; Daniel Landau; Peter Meyer; Hanna Shalev; Maria Tsolia; Zvi Borochowitz; Melanie Barbara Boettger; Gretel E Beck; Richard K Englehardt; Rivka Carmi; Val C Sheffield
Journal:  Nat Genet       Date:  2002-05-28       Impact factor: 38.330

6.  Expression and Up-regulation of alternatively spliced transcripts of melastatin, a melanoma metastasis-related gene, in human melanoma cells.

Authors:  D Fang; V Setaluri
Journal:  Biochem Biophys Res Commun       Date:  2000-12-09       Impact factor: 3.575

7.  ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology.

Authors:  A L Perraud; A Fleig; C A Dunn; L A Bagley; P Launay; C Schmitz; A J Stokes; Q Zhu; M J Bessman; R Penner; J P Kinet; A M Scharenberg
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

8.  The light response of ON bipolar neurons requires G[alpha]o.

Authors:  A Dhingra; A Lyubarsky; M Jiang; E N Pugh; L Birnbaumer; P Sterling; N Vardi
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

9.  TRPM1 mutations are associated with the complete form of congenital stationary night blindness.

Authors:  Makoto Nakamura; Rikako Sanuki; Tetsuhiro R Yasuma; Akishi Onishi; Koji M Nishiguchi; Chieko Koike; Mikiko Kadowaki; Mineo Kondo; Yozo Miyake; Takahisa Furukawa
Journal:  Mol Vis       Date:  2010-03-12       Impact factor: 2.367

10.  A transient receptor potential channel expressed in taste receptor cells.

Authors:  Cristian A Pérez; Liquan Huang; Minqing Rong; J Ashot Kozak; Axel K Preuss; Hailin Zhang; Marianna Max; Robert F Margolskee
Journal:  Nat Neurosci       Date:  2002-11       Impact factor: 24.884

View more
  50 in total

1.  TRPM1 forms complexes with nyctalopin in vivo and accumulates in postsynaptic compartment of ON-bipolar neurons in mGluR6-dependent manner.

Authors:  Yan Cao; Ekaterina Posokhova; Kirill A Martemyanov
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

Review 2.  Why rods and cones?

Authors:  T D Lamb
Journal:  Eye (Lond)       Date:  2015-11-13       Impact factor: 3.775

3.  Sensitivity and kinetics of signal transmission at the first visual synapse differentially impact visually-guided behavior.

Authors:  Ignacio Sarria; Johan Pahlberg; Yan Cao; Alexander V Kolesnikov; Vladimir J Kefalov; Alapakkam P Sampath; Kirill A Martemyanov
Journal:  Elife       Date:  2015-04-16       Impact factor: 8.140

4.  Sorting out co-occurrence of rare monogenic retinopathies: Stargardt disease co-existing with congenital stationary night blindness.

Authors:  Nancy Huynh; Brett G Jeffrey; Amy Turriff; Paul A Sieving; Catherine A Cukras
Journal:  Ophthalmic Genet       Date:  2014-01-07       Impact factor: 1.803

5.  Photoreceptor and postreceptor responses in congenital stationary night blindness.

Authors:  Aparna Raghuram; Ronald M Hansen; Anne Moskowitz; Anne B Fulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-10       Impact factor: 4.799

6.  Nonlinearity and noise at the rod-rod bipolar cell synapse.

Authors:  E Brady Trexler; Alexander R R Casti; Yu Zhang
Journal:  Vis Neurosci       Date:  2010-11-04       Impact factor: 3.241

Review 7.  Ca2+ as a therapeutic target in cancer.

Authors:  Scott Gross; Pranava Mallu; Hinal Joshi; Bryant Schultz; Christina Go; Jonathan Soboloff
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

8.  Orphan receptor GPR179 forms macromolecular complexes with components of metabotropic signaling cascade in retina ON-bipolar neurons.

Authors:  Cesare Orlandi; Yan Cao; Kirill A Martemyanov
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-29       Impact factor: 4.799

Review 9.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

10.  Kainate receptors: on the dark side.

Authors:  Malcolm M Slaughter
Journal:  J Physiol       Date:  2014-04-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.